These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36206987)

  • 1. The implications of the Fetal Medicine Foundation 35- to 36-week preeclampsia prediction competing-risk model on timing of birth.
    von Dadelszen P; Syngelaki A; Wright A; Akolekar R; Magee LA; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2023 Apr; 228(4):457.e1-457.e7. PubMed ID: 36206987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble fms-like tyrosine kinase-1/placental growth factor ratio at 36 weeks' gestation: association with spontaneous onset of labor and intrapartum fetal compromise in low-risk pregnancies.
    Farina A; Cavoretto PI; Syngelaki A; Adjahou S; Nicolaides KH
    Am J Obstet Gynecol; 2024 Aug; ():. PubMed ID: 39181498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2022 Aug; 227(2):294.e1-294.e11. PubMed ID: 35276067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
    Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
    Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of imminent preeclampsia at 35-37 weeks gestation.
    Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal vascular indices at 36 weeks' gestation in the prediction of preeclampsia.
    Mansukhani T; Wright A; Arechvo A; Lamanna B; Menezes M; Nicolaides KH; Charakida M
    Am J Obstet Gynecol; 2024 Apr; 230(4):448.e1-448.e15. PubMed ID: 37778678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth.
    Sovio U; Gaccioli F; Cook E; Charnock-Jones DS; Smith GCS
    Am J Obstet Gynecol; 2023 Aug; 229(2):164.e1-164.e18. PubMed ID: 36758709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additive role of angiogenic markers for women with confirmed preeclampsia.
    Suresh S; Patel E; Mueller A; Morgan J; Lewandowski WL; Verlohren S; von Dadelszen P; Magee LA; Rana S
    Am J Obstet Gynecol; 2023 May; 228(5):573.e1-573.e11. PubMed ID: 36356699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial.
    Palma Dos Reis CR; O'Sullivan J; Ohuma EO; James T; Papageorghiou AT; Vatish M; Cerdeira AS
    Am J Obstet Gynecol; 2024 Jun; ():. PubMed ID: 38897339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester risk of preeclampsia and rate of spontaneous birth in patients without preeclampsia.
    Cavoretto PI; Farina A; Salmeri N; Syngelaki A; Tan MY; Nicolaides KH
    Am J Obstet Gynecol; 2024 Oct; 231(4):452.e1-452.e7. PubMed ID: 38244830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor.
    Sovio U; Gaccioli F; Cook E; Charnock-Jones DS; Smith GCS
    Am J Obstet Gynecol; 2021 Nov; 225(5):520.e1-520.e10. PubMed ID: 33901486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing-risks model for pre-eclampsia and adverse pregnancy outcomes.
    Syngelaki A; Magee LA; von Dadelszen P; Akolekar R; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):367-372. PubMed ID: 35866878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is gestational age at term a risk factor for ongoing pregnancies in nulliparous women: A prospective cohort study.
    Quibel T; Rozenberg P; Duvillier C; Bouyer C; Bouyer J
    Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100808. PubMed ID: 36371036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
    Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
    Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.